Familiáris hiperkoleszterinémia: vizsgálatok itt: Franciaország
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Bron, Toulouse Cedex 9
- Életkor
- 6 év to 17 év
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - 3. fázisNot yet taking people in FranciaországStudy to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia
- Where
- Paris
- Életkor
- Up to 17 év
- People
- 8 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-514595-41-00 - 3. fázisFut, nem toborozLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Besançon, Toulouse
- Életkor
- 2 év to 100 év
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - No phaseTaking peopleAssessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
- Where
- Paris
- Életkor
- 12 év and over
- People
- 52 worldwide
- Run by
- Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
See details and how to joinNCT07447648 - No phaseTaking people"Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"
- Where
- Paris
- Életkor
- 30 év to 60 év
- People
- 300
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07427472 - 3. fázisTaking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Marseille, Nantes, Paris
- Életkor
- 6 év to 11 év
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019 - No phaseTaking peopleStudy of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
- Where
- Dijon, Lille, Lyon, Marseille, Nantes, Paris, Rennes, Strasbourg
- Életkor
- 40 év and over
- People
- 600
- Run by
- Nantes University Hospital
See details and how to joinNCT06960902 - No phaseTaking peopleScreening for Familial Hypercholesterolemia in Children
- Where
- Amiens
- Életkor
- 2 év to 18 év
- People
- 300
- Run by
- Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT06555120 - No phaseTaking peopleEffect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia
- Where
- Lille
- Életkor
- 18 év to 70 év
- People
- 35
- Run by
- Institut Pasteur de Lille
See details and how to joinNCT06894251